Viewing Study NCT02807805


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-02-25 @ 5:50 PM
Study NCT ID: NCT02807805
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-12-18
First Post: 2016-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Sponsor: Mamta Parikh
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Prostate Carcinoma View
None Recurrent Prostate Carcinoma View
None Stage IV Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None castration resistant prostate cancer View